Rhino Health, a Cambridge, Mass.-based provider of AI-based healthcare solutions, closed a $5m seed financing round.
The round was led by LionBird Ventures, with participation from Arkin Holdings and several angel investors.
Led by CEO Ittai Dayan, MD, and Yuval Baror, CTO, Rhino provides a health platform that connects hospitals and AI developers, providing access to a large, continually updated, distributed dataset from a diverse group of patients.
The company and NVIDIA are collaborating to bring the benefits of Federated Learning into the clinical setting. With the platform, using NVIDIA Clara, the companies are empowering the clinical community to build AI models across different geographies, institutions, medical devices and patient demographics.
Rhino Health – now a member of the NVIDIA Inception program – also has an R&D Center in Tel Aviv, Israel.